£830K
Mogrify secures £830k in Phase II grant funding from SBRI Healthcare for cartilage therapy assessment.
The Phase II grant from SBRI Healthcare will fund pre-clinical safety and efficacy studies for regenerative cartilage treatments.
"We select projects strategically based on both commercial and scientific considerations and are delighted with the progress of this collaboration with Dr. Wael Kafienah’s laboratory at the University of Bristol. The continued support for our lead musculoskeletal asset from SBRI Healthcare has not only allowed us to reach this phase but will enable us to carry the chondrocyte conversions through to the next stage."

